Dear Editor,In 1893, Mibelli and Respighi coined the term porokeratosis assuming that the columns of
parakeratosis emerged from the ostia of eccrine ducts. Later on, it turned out to be a
misnomer when lesions were proved to result from a clonal disorder of keratinization
characterized by the appearance of atrophic patches surrounded by the cornoid
lamella.[1,2] Although the disorder is inherited in an autosomal
dominant trait with incomplete penetrance, most cases are caused by sporadic
mutations.[3,4]Porokeratosis subtypes include the classic porokeratosis of Mibelli, disseminated
superficial porokeratosis, disseminated superficial actinic porokeratosis, punctate
porokeratosis, porokeratosis palmaris et plantaris disseminata and linear
porokeratosis.Linear porokeratosis can be further subdivided in localized, zosteriform, systematized,
and generalized. A patient can present more than one type of porokeratosis and any part
of the body can be involved.A 24-year-old woman was referred to our unit with a history of pityriasis rubra pilaris
in her lower right leg that had been diagnosed at the age of 6 months. Treatments with
corticosteroid and antifungal creams showed no improvement. The lesions were anhidrotic,
and present pruritus when exposed to sunlight. Gradually, they expanded to the face,
neck, right leg, arm, palm and sole, but remained always restricted to the right
hemibody.Physical examination revealed deep red to brownish, atrophic plaques with a prominent
peripheral hyperkeratotic ridge, coalescing on the lower right leg and the sole,
assuming a linear distribution following the Blaschko lines (Figure 1). Similar lesions were present on her face, neck, right
arm, and palm and a dorsal pterygium developed on the index finger (Figure 2).
Figure 1
Deep red to brownish, atrophic plaques with a prominent peripheral
hyperkeratotic ridge, coalescing on the lower right limb, including the sole
and assuming a linear distribution, following the Blaschko lines
Figure 2
Right arm lesions and dorsal pterygium in the proximal nail fold of the right
index finger
Deep red to brownish, atrophic plaques with a prominent peripheral
hyperkeratotic ridge, coalescing on the lower right limb, including the sole
and assuming a linear distribution, following the Blaschko linesRight arm lesions and dorsal pterygium in the proximal nail fold of the right
index fingerBiopsies of the peripheral ridge and the central atrophic areas revealed the presence of
cornoid lamella with loss of the granular layer, and focal lymphocytic infiltrate (Figure 3).
Figure 3
Skin with epidermal hyperkeratosis and presence of a characteristic
parakeratotic column (cornoid lamella). There is mild edema in the papillary
dermis and presence of inflammatory infiltrate with lymphocyte predominance
(Hematoxilin & eosine, X20)
Skin with epidermal hyperkeratosis and presence of a characteristic
parakeratotic column (cornoid lamella). There is mild edema in the papillary
dermis and presence of inflammatory infiltrate with lymphocyte predominance
(Hematoxilin & eosine, X20)Linear porokeratosis is a strictly unilateral variant with grouped acral lesions and
pathology findings identical to those observed in porokeratosis of Mibelli.[5] Lesions vary in size, height, and
number, may involve the entire hemibody, and slowly grow to form irregular annular
plaques with well-demarcated raised borders. The central portion generally presents
anhidrosis and alopecia.Classic porokeratosis of Mibelli, disseminated superficial actinic porokeratosis,
porokeratosis palmaris et plantaris disseminata, and punctate porokeratosis are all of
autosomal dominant inheritance. Porokeratosis of Mibelli and linear porokeratosis may
occur through mosaicism. Reports of coexisting disseminated superficial actinic
porokeratosis and linear porokeratosis raise the possibility of a common genetic
aberration at chromosomes 12, 15, or 18.[2,4,5]Risk factors for porokeratosis include skin burn or damage by ultraviolet radiation A and
B, and immunosuppression.[2]The cornoid lamella is a constant finding in all variants of porokeratosis. It is formed
by a thick column of parakeratotic cells extending outward from a notch in the
malpighian layer of the epidermis and forms the raised ridgelike border of the clinical
lesion. The cornoid lamella arises in the interfollicular epidermis, extending through
the entire corneum stratum. The granular layer is absent and vacuolated keratinocytes
can be visualized at the base of the lamella.Disseminated superficial actinic porokeratosis lesions are small and discrete keratotic
papules, with a a less prominent ridge, uniformly distributed on sun-exposed areas.Porokeratosis palmaris et plantaris disseminata lesions appear on the palms and soles.
The keratotic ridge is more pronounced and pruritic. This variant and linear
porokeratosis rarely cause bone and/or nail dystrophy.Punctate porokeratosis lesions are discrete with a thin peripheral ridge.Diagnosis is clinically confirmed with visualization of a continuous ridge and
histopathologic demonstration of the cornoid lamellae.Most linear porokeratoses present a difficult differential diagnosis with porokeratotic
eccrine ostial and dermal duct nevus.The latter presents as multiple linear punctuate pits or keratotic plaques and papules
that resemble linear porokeratosis. However, histopathology examination shows epidermal
invaginations containing a cornoid lamella that involves the eccrine ducts and hair
follicles.Other differential diagnoses include linear psoriasis, inflammatory linear verrucous
epidermal nevus, lichen striatus, incontinentia pigmenti, and pityriasis rubra
pilaris.Up to 20% of the cases with porokeratosis may undergo malignant transformation into basal
cell carcinoma or Bowen disease. Fatal outcomes from disseminated squamous cell
carcinoma associated with porokeratosis have been reported. Protein p53 has been
considered as a possible marker of malignant degeneration in patients with confirmed
porokeratosis.[2]Treatment includes surgery, cryotherapy, dermabrasion, electrodissection or CO2 laser.
Successful treatment has been reported with 5-fluorouracil and imiquimod cream (5%).
Retinoid therapy has yielded inconsistent results. A strict patient follow-up is
recommended due to risk of malignancy.